Sharda Cropchem

Sharda CropChem reported revenue from operations of ₹2,065 crore, up 13 per cent from ₹1,829 crore in the year-ago period

Stocks to buy today: Sharda Cropchem has seen a decisive surge, followed by some profit booking, while SMS Pharmaceuticals has experienced a gradual resurgence over the last couple of trading sessions

Stocks like BSE, KRBL, Prestige Estates, Sharda Cropchem and Sumitomo Chemical are seen exiting oversold zone and can potentially rally up to 16 per cent in the ensuing pullback, suggest daily charts.

As many as 10 stocks within the Nifty 500 space have declined over 20 per cent so far in 2024. These are the key levels to watch out, suggest charts.

The company's revenues during the quarter declined 22.7 per cent YoY to Rs 638 crore due to lower sales in Europe and The North American Free Trade Agreement (NAFTA) Region.

Analysts expect the company to show high growth momentum, strong balance sheet, free cash-flows and strong return ratios over FY22-24.

Sharda Cropchem rallied 8.3 per cent, while Deepak Fertilisers was locked in the 5 per cent upper circuit as the two hit their respective all-time highs on the BSE in Friday's intra-day trade.

Shares of Sharda Cropchem hit a new high of Rs 578.35 after they rallied 10 per cent on the BSE in Thursday's in intra-day trade

Market wrap: Sensex crashes 1,546 pts, Nifty below 17,150 amid Fed suspense

Broader markets worst hit, BSE SmallCap index slips over 4%; BSE IPO index plunges 7% as Zomato, Nykaa tank up to 20%

EBITDA margin expanded by 220 bps YoY to 22.8 per cent in Q3FY22 driven by economies of scale, effective cost management marginally settled off by higher freight cost.

These companies reported an increase in revenue and/or profit before tax for the March quarter

The agrochemicals company reported profit of Rs 106 crore in Q4FY16 against Rs 48 crore in Q4FY15.